Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275600 · ClinicalTrials.gov registry record · Phase 2
Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Breast Pain
A Phase 2 study of Cyclical Breast Pain, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT00275600: Completed Phase 2 study of Cyclical Breast Pain, sponsored by Mayo Clinic.
NCT00275600 is a Phase 2 study of Cyclical Breast Pain that has completed, run by Mayo Clinic. The registered enrollment target is 82 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275600, a Phase 2 study of Cyclical Breast Pain, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to find out what effects Vitamin E or Evening Oil of Primrose has on cyclical breast pain.
Conditions Studied
Interventions
- DRUG Vitamin E, Evening Oil of Primrose, and Placebo
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2003-01 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
What the finished NCT00275600 record still lists
NCT00275600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Cyclical Breast Pain appearing as the primary indexed condition, and to 1 intervention - of which Vitamin E, Evening Oil of Primrose, and Placebo is the first listed.
NCT00275600 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00275600 about?
NCT00275600 is a clinical study titled "Randomized Clinical Trial of Vitamin E and Evening Oil of Primrose for the Managment of Breast Pain". This study is being done to find out what effects Vitamin E or Evening Oil of Primrose has on cyclical breast pain.
What is the current status of trial NCT00275600?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 82 participants. The study started on 2003-01. Estimated completion is 2007-09.
What conditions does trial NCT00275600 study?
This clinical trial studies the following conditions: Cyclical Breast Pain.
What interventions are being tested in trial NCT00275600?
The interventions under investigation include: Vitamin E, Evening Oil of Primrose, and Placebo (DRUG).
Who is sponsoring clinical trial NCT00275600?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00275600 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00275600's enrollment target sits among peer trials
82 830th of 2000 higher than 1,167 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia